CNXCConcentrix Corporation

$25.95-53% 1Y

Is the price fair?

Good

Undemanding: modest expectations priced in and cheap against its own history.

2 good, 1 without data
What the price assumes~−24% a yearderived · May 31, 2026

Priced for a decline (~−24% a year). The price demands less than its three-year revenue growth of 16% a year, expectations look modest.

Vs its own P/E rangecheapest in 19 quartersderived

Cheap vs its own history: P/E 10.8 vs a 14.9 median over 19 quarters (−27% vs median).

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

FCF yieldtop 1% of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What CNXC's price assumes

Today's price asks for −24% free cash flow growth a year; over the last three years Concentrix Corporation delivered 1.9%, less than the record.

0.14

Price / sales · no P/E: the last twelve months did not end in a profit

Free cash flow yield
37%

Free cash flow yield · Information Technology Services median 12%

Growth the price implies
−24%

Growth the price implies · The price pays for −24% free cash flow growth a year for a decade; the business has delivered +1.9% a year over the last three.

Price / book
0.51

Price / book · today's price, trailing year to May 31, 2026

Details›
Price / booktoday's price, trailing year to May 31, 2026
0.51
EV / EBIToperating margin −10%: the multiple describes the denominator
not meaningful
EV / salestoday's price, trailing year to May 31, 2026
0.57
Free cash flow, trailing twelve months
$514M
Market capitalisation
$1.37B
3-year revenue growth
+16%
3-year free cash flow growth
+1.9%

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

On our screens:Most shorted stocks